Constructive news tone
News Sentiment
PHIO sentiment intelligence
Phio Pharmaceuticals Corp news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Constructive news tone is being confirmed by positive weekly price action.
83/100 classification confidence.
directly relevant articles
high-authority source matches
+1.0% over one week, +0.0% over four weeks, trend inactive, and below fair value.
Phio Pharmaceuticals appoints dermatologist to board By Investing.com
Market Reaction
News confirmed by price
Constructive news tone is being confirmed by positive weekly price action.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
Phio Pharmaceuticals Announces "Innovations in Skin Cancer Treatment and Prevention" in a Fireside Chat with Force Family Office on Tuesday, May 19, 2026
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 May 2026 11:00
- Source
- TMX Newsfile
Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- simplywall.st
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
Phio CEO heads to Nasdaq Marketsite for April 14 investor presentation
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Apr 2026 07:00
- Source
- Stock Titan
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Mar 2026 07:00
- Source
- TradingView
Phio Pharmaceuticals Reports 2025 Year-End Financial Results and Business Update
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 05 Mar 2026 08:00
- Source
- TMX Newsfile
Phio Pharmaceuticals stock soars after strong cancer treatment results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 10 Feb 2026 08:00
- Source
- Investing.com
Phio Pharmaceuticals (PHIO) Stock Price, News & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Mar 2019 06:34
- Source
- MarketBeat